NCT03402854 tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy
| NCT ID | NCT03402854 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Burke Medical Research Institute |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2019-12-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2019-12-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to test the efficacy of transcranial direct current stimulation combined with bimanual training on hand function in children with unilateral spastic cerebral palsy (USCP). Children who enroll in the protocol will be randomized to receive either sham (not stimulating) tDCS plus bimanual training, or active (stimulating) tDCS plus bimanual training.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of congenital hemiplegic cerebral palsy * Ability to lift and grasp light objects with affected hand * Ability to extend wrist of affected hand 15 degrees * Ability to follow instructions and provide informed assent * Parent(s) able to provide informed consent Exclusion Criteria: * Seizures after age 2 years * Spasticity medication within 6 months before study * Selective dorsal rhizotomy * Surgery in affected upper extremity within year before study
Contact & Investigator
Kathleen M Friel, PhD
PRINCIPAL INVESTIGATOR
Burke Medical Research Institute
Frequently Asked Questions
Who can join the NCT03402854 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03402854 currently recruiting?
Yes, NCT03402854 is actively recruiting participants. Contact the research team at kaf3001@med.cornell.edu for enrollment information.
Where is the NCT03402854 trial being conducted?
This trial is being conducted at White Plains, United States.
Who is sponsoring the NCT03402854 clinical trial?
NCT03402854 is sponsored by Burke Medical Research Institute. The principal investigator is Kathleen M Friel, PhD at Burke Medical Research Institute. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.